Baculoviral delivery of CRISPR/Cas9 facilitates efficient genome editing in human cells

被引:33
|
作者
Hindriksen, Sanne [1 ]
Bramer, Arne J. [1 ]
My Anh Truong [1 ]
Vromans, Martijn J. M. [1 ]
Post, Jasmin B. [1 ]
Verlaan-Klink, Ingrid [1 ]
Snippert, Hugo J. [1 ]
Lens, Susanne M. A. [1 ]
Hadders, Michael A. [1 ]
机构
[1] Univ Med Ctr Utrecht, Sect Mol Canc Res, Ctr Mol Med, Univ Weg 100, Utrecht, Netherlands
来源
PLOS ONE | 2017年 / 12卷 / 06期
关键词
CHROMOSOMAL PASSENGER COMPLEX; AURORA-B; MAMMALIAN-CELLS; GENE-EXPRESSION; HISTONE H3; HOMOLOGOUS RECOMBINATION; MULTIPROTEIN COMPLEXES; SPINDLE CHECKPOINT; VERTEBRATE CELLS; STEM-CELLS;
D O I
10.1371/journal.pone.0179514
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The CRISPR/Cas9 system is a highly effective tool for genome editing. Key to robust genome editing is the efficient delivery of the CRISPR/Cas9 machinery. Viral delivery systems are efficient vehicles for the transduction of foreign genes but commonly used viral vectors suffer from a limited capacity in the genetic information they can carry. Baculovirus however is capable of carrying large exogenous DNA fragments. Here we investigate the use of baculoviral vectors as a delivery vehicle for CRISPR/Cas9 based genome-editing tools. We demonstrate transduction of a panel of cell lines with Cas9 and an sgRNA sequence, which results in efficient knockout of all four targeted subunits of the chromosomal passenger complex (CPC). We further show that introduction of a homology directed repair template into the same CRISPR/Cas9 baculovirus facilitates introduction of specific point mutations and endogenous gene tags. Tagging of the CPC recruitment factor Haspin with the fluorescent reporter YFP allowed us to study its native localization as well as recruitment to the cohesin subunit Pds5B.
引用
收藏
页数:25
相关论文
共 50 条
  • [41] Modeling human disease in rodents by CRISPR/Cas9 genome editing
    Birling, Marie-Christine
    Herault, Yann
    Pavlovic, Guillaume
    MAMMALIAN GENOME, 2017, 28 (7-8) : 291 - 301
  • [42] Exosomes as Targeted Delivery Platform of CRISPR/Cas9 for Therapeutic Genome Editing
    Duan, Li
    Ouyang, Kan
    Wang, Jianhong
    Xu, Limei
    Xu, Xiao
    Wen, Caining
    Xie, Yixin
    Liang, Yujie
    Xia, Jiang
    CHEMBIOCHEM, 2021, 22 (24) : 3360 - 3368
  • [43] Editing the genome in cells and mice using CRISPR/Cas9 technology
    Herold, M. J.
    Aubrey, B. J.
    Kelly, G. L.
    Kueh, A. J.
    Brennan, M. S.
    O'Connor, L.
    Milla, L.
    Wilcox, S.
    Tai, L.
    Strasser, A.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 10 - 10
  • [44] CRISPR/Cas9 Delivery System Engineering for Genome Editing in Therapeutic Applications
    Cheng, Hao
    Zhang, Feng
    Ding, Yang
    PHARMACEUTICS, 2021, 13 (10)
  • [45] Genome Editing in Erythroid Progenitor Cells Mediated By Crispr/Cas9
    Li, Hojun
    Shi, Jiahai
    Lodish, Harvey F.
    BLOOD, 2014, 124 (21)
  • [46] CRISPR/CAS9 GENOME EDITING FOR NEURODEGENERATIVE DISEASES
    Nojadeh, Jafar Nouri
    Eryilmaz, Nur Seren Bildiren
    Erguder, Berrin Imge
    EXCLI JOURNAL, 2023, 22 : 567 - 582
  • [47] CRISPR/CAS9, the king of genome editing tools
    A. V. Bannikov
    A. V. Lavrov
    Molecular Biology, 2017, 51 : 514 - 525
  • [48] Advances in therapeutic CRISPR/Cas9 genome editing
    Schwank, G.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1053 - 1053
  • [49] Virus-Like Particle Mediated CRISPR/Cas9 Delivery for Efficient and Safe Genome Editing
    Lyu, Pin
    Wang, Luxi
    Lu, Baisong
    LIFE-BASEL, 2020, 10 (12): : 1 - 16
  • [50] CRISPR/CAS9: THE GOLD STANDARD OF GENOME EDITING?
    Gleeson, Alfie
    Sawyer, Abigail
    BIOTECHNIQUES, 2018, 64 (06) : 239 - 244